New England Journal of Medicine
January 21, 2021 Vol. 384 No. 3
http://www.nejm.org/toc/nejm/medical-journal

Original Articles
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease – E.B. Esrick and Others